DZL-23603-76818
3 vaccinations
5 coded responses
37 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 906 / CA
- Registered
- 2021-03-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Registered in v-safe
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
-
2021-04-12
Dose 2 — Pfizer-BioNTech
- 2021-04-12
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
-
2021-05-24
Survey response — day 42, dose 2MedDRA: Diarrhoea, Norovirus infection, Pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Norovirus diarrhea and body aches, 1 day, no fever or other symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-12
- 2021-10-11
-
2021-11-04
Dose 3 — Pfizer-BioNTech
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-18
- 2021-11-25
-
2021-12-02
Survey response — day 28, dose 3MedDRA: Fatigue, Headache, Nasal congestion, SARS-CoV-2 test negative — Feeling: FairFree text: Nasal congestion and headache and fatigue. I believe I have a basic sinus infection that I got from my niece. I took a home Covid test which came back negative.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-09
Survey response — day 35, dose 3MedDRA: Heavy menstrual bleeding, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: Bad cold, lasted 10 days, home Covid test came back negative; After this dose as well as my first doses I had a heavier than usual menstrual cycle.MedDRA releases: 2024-11 · check-in free text available
- 2021-12-16
-
2022-02-03
Survey response — 3 months, dose 3MedDRA: Lipoma of breast, Lymphadenopathy, Mammogram abnormal, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Abnormal mammogram Lipoma or enlarged lymph node in R breast; pending ultrasound · Healthcare visit (other): Follow up ultrasoundMedDRA releases: 2024-11 · check-in free text available
-
2022-02-03
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-30
- 2022-05-05
-
2022-11-04
Survey response — 12 months, dose 3MedDRA: Fatigue, Headache, Pain, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid 19 positive test; severe headache; body aches; low fever; fatigueMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-12 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 42, dose 2
Symptoms: Norovirus diarrhea and body aches, 1 day, no fever or other symptoms.
Release 10 — day 28, dose 3
Symptoms: Nasal congestion and headache and fatigue. I believe I have a basic sinus infection that I got from my niece. I took a home Covid test which came back negative.
Release 10 — day 35, dose 3
Symptoms: Bad cold, lasted 10 days, home Covid test came back negative; After this dose as well as my first doses I had a heavier than usual menstrual cycle.
Release 11 — 3 months, dose 3
Symptoms: Abnormal mammogram Lipoma or enlarged lymph node in R breast; pending ultrasound
Healthcare visit (other): Follow up ultrasound
Release 12 — 12 months, dose 3
Symptoms: Covid 19 positive test; severe headache; body aches; low fever; fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Lipoma of breast | · | · | ✓ |
| SD | Lymphadenopathy | · | · | ✓ |
| SD | Mammogram abnormal | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Norovirus infection | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release